News about Global Pharma

Frontier Scientific Solutions Announces Appointment of Keith Parent as CTO

Frontier Scientific Solutions, a provider of GMP temperature-controlled storage and Free Trade Zone (FTZ) services for the life sciences industry, announced the appointment of Keith Parent as Chief Technology Officer (CTO).

Global Pharma | 04/03/2025 | By Manvi |  429

Zydus to Develop Combination Vaccine for Shigellosis and Typhoid

Zydus Lifesciences Ltd. has announced the development of the world’s first combination vaccine for shigellosis and typhoid, supported by the Gates Foundation, to address critical gaps in childhood immunization.

Global Pharma | 04/03/2025 | By Manvi |  159

Eton Pharmaceuticals Introduces Galzin Capsules for Wilson Disease

Galzin is FDA-approved for the maintenance treatment of patients with Wilson disease who have been initially treated with a chelating agent.

Global Pharma | 04/03/2025 | By Aishwarya |  383

Biotech Fluidics Launches New Flowmeter Kit to Validate Performance of HPLC Pump

The HPLC Pump Validation Kit has been designed to accept raw data generated by the Biotech Fluidics Liquid Flowmeter PC-App and it performs all necessary flow calculations automatically.

Global Pharma | 04/03/2025 | By Aishwarya |  307

Novo Holdings Invests in Series A Launch Financing for Callio Therapeutics

The oversubscribed Series A financing was led by Frazier Life Sciences, with significant participation from Novo Holdings and other life sciences investors including Jeito Capital, Omega Funds, Norwest, ClavystBio, EDBI, Platanus, Pureos Bioventures and SEEDS Capital.

Global Pharma | 04/03/2025 | By Aishwarya |  713

CHMP Recommends T-DXd EU Approval in HER2-Low/Ultralow Breast Cancer

ENHERTU is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca.

Global Pharma | 04/03/2025 | By Aishwarya |  321

IDEAYA Biosciences Teams Up with ATTMOS to Tackle Undruggable Oncology Targets

IDEAYA Biosciences, Inc. announced a research collaboration with ATTMOS as part of its efforts to build a physics-based computational small molecule discovery platform that rapidly unlocks what are currently perceived as undruggable oncology targets.

Global Pharma | 03/03/2025 | By Manvi |  185

Glenmark Pharmaceuticals Acquires and Launches Acetylcysteine Injection in US

Glenmark Pharmaceuticals Inc., USA, has acquired the ANDA for Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials from Aspen Pharma USA Inc and launched it in the US market.

Global Pharma | 03/03/2025 | By Manvi |  498

Renovaro and BioSymetrics to Boost AI-Driven Biomarker Discovery and Precision Medicine

At the core of this collaboration is BioSymetrics’ proprietary Elion platform, a cutting-edge AI and machine learning engine that uncovers complex biological relationships to accelerate the discovery of diagnostics and therapeutics.

Global Pharma | 03/03/2025 | By Aishwarya |  323

Akums Signs MoU with NIFTEM-T to Strengthen Industry-Academia Partnership

Under this agreement, NIFTEM-T students will be provided with internship opportunities at Akums, allowing them to gain hands-on industry experience.

Global Pharma | 03/03/2025 | By Aishwarya |  492